http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13290033

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article
endingPage 968
issn 0007-0920
1532-1827
issueIdentifier 7
pageRange 964-968
publicationName British Journal of Cancer
startingPage 964
bibliographicCitation Sharma R, Rivory L, Beale P, Ong S, Horvath L, Clarke SJ. A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer. British Journal of Cancer. 2006 Mar 21;94(7):964–8. doi: 10.1038/sj.bjc.6603049.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0363d6c61b8743d9ece71c4d7d8a5709
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30ac9f4ed23acfad094e1ea8b6a93d8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f562da928d79fd96ed4e875e389f6a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce60eaba78ec35a51a3a5cd694d06c8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f8dff00f38463885bcc8f9fbd0a1f45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4f448648e96acd81db71fceda524693
date 2006-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2361225
https://doi.org/10.1038/sj.bjc.6603049
https://pubmed.ncbi.nlm.nih.gov/16552436
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer
discusses http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0010514
http://id.nlm.nih.gov/mesh/M0008658
http://id.nlm.nih.gov/mesh/M0287377
http://id.nlm.nih.gov/mesh/M0008631
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11386
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128204655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128321989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129909512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129583715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129555111

Total number of triples: 63.